The bioassay-guided purification of the ethanol extracts of Acmella pilosa and Cnidoscolus souzae, two plants of the native flora of the Yucatan Peninsula used in traditional medicine to treat inflammation and pain, resulted in the identification of rosmarinic acid (1) and caffeic acid (2) as the bioactive metabolites from A. pilosa, and of 7-deoxynimbidiol (4) as the major bioactive metabolite from C. souzae. Metabolites 1, 2, and 4 proved to be responsible for the antioxidant activity originally detected in the corresponding organic crude extracts; 7-deoxynimbidiol (4) showed good analgesic and anti-inflammatory activities, inhibiting the pain induced by PGE2 and reducing the edema induced by carrageenan, respectively.
Méndez-GonzálezM.E., Garcia-DuránR., Bobadilla-CamposM.S., Dorantes EuanA.Flora medicinal. In Biodiversidad y Desarrollo Humano en Yucatán.Méndez GonzálezM., Durán GarciaR. (Eds) (2011) Mérida, Yucatán, México: CICY, PPD-FMAM, CONABIO, SEDUMA.349–352.
2.
AnkliA., SticherO., HeinrichM. (1999) Medical ethnobotany of the Yucatec Maya: Healers consensus as a quantitative criterion. Economic Botany, 53, 144–160.
3.
DuránR., Trejo-TorresJ.C., Ibarra-ManríquezG. (1998) Endemic phytotaxa of the peninsula of Yucatán. Harvard University Herbaria, 3, 263–314.
4.
BlockL.C., SantosA.R., de SouzaM.M., ScheidtC., YunesR.A., SantosM.A., MonacheFD, FilhoV.C. (1998) Chemical and pharmacological examination of antinociceptive constituents of Wedelia paludosa. Journal of Ethnopharmacology, 61, 85–89.
5.
RanhotraG.S., GelrothJ.A., LeinenS.D., VinM.A. (1998) Nutritional profile of some edible plants from Mexico. Journal of Food Composition and Analysis, 304, 298–304.
6.
KoltermannD.A., BreckonG.J., KowalR.R. (1984) Chemotaxonomic studies in Cnidoscolus (Euphorbiaceae). II. Flavonoids of C. aconitifolius, C. souzae, and C. spinosus. Systematic Botany, 7, 178–185.
7.
YuanW., LiS., OwnbyS., ZhangZ., WangP., ZhangW., BeasleyR.S. (2007) Flavonoids, coumarins and triterpenes from the aerial parts of Cnidoscolus texanus. Planta Medica, 73, 1304–1308.
8.
Zapata-EstrellaH.E., Sima-PolancoS., Escalante-ErosaF., García-SosaK., Cechinel-FilhoV., Meira-QuintãoN.L., Peña-RodríguezL.M. (2014) Antioxidant and analgesic activity of medicinal plants from the native flora of the Yucatan peninsula. Journal of Ethnopharmacology. Submitted.
9.
Brand-WilliamsW., CuvelierM.E., BersetC. (1995) Use of a free radical method to evaluate antioxidant activity. LWT - Food Science and Technology, 28, 25–30.
10.
Reza-GohariA., SoodabehS., ShahverdiA.R., YassaN., MalmirM., MollazadeK., NaghinejadA.R. (2009) Phytochemistry and antimicrobial compounds of Hymenocrater calycinus. Eurasian Journal of Biosciences, 68, 64–68.
JeongC.H., JeongH.R., ChoiG.N., KimD.O., LeeU., HeoH.J. (2011) Neuroprotective and anti-oxidant effects of caffeic acid isolated from Erigeron annuus leaf. Chinese Medicine, 6, 25–33.
13.
Eun-RhanW., Mei ShanP. (2004) Antioxidative constituents from Lycopus lucidus. Archives of Pharmacal Research, 27, 173–176.
14.
Campos DeF., FranzoiC.L., AntoniniG., FracassoM., Cechinel-FilhoV., AugustoY.R., NieroR. (2009) Antinociceptive properties of caffeic acid derivatives in mice. European Journal of Medicinal Chemistry, 44, 4596–4602.
15.
Gamaro-DuzzoG., SuyenagaE., BorsoiM., LermenJ., PereiraP., ArdenghiP. (2011) Effect of rosmarinic and caffeic acids on inflammatory and nociception process in rats. International Scholarly Research Network, 1–6.
16.
GuginskiG., LuizA.P., SilvaM.D., MassaroM., MartinsD.F., ChavesJ., SantosA.R.S. (2009) Mechanisms involved in the antinociception caused by ethanolic extract obtained from the leaves of Melissa officinalis (lemon balm) in mice. Pharmacology, Biochemistry, and Behavior, 93, 10–16.
17.
XiongY., WangK., PanY., SunH., TuJ. (2006) Isolation, synthesis, and anti-tumor activities of a novel class of podocarpic diterpenes. Bioorganic Medicinal Chemistry Letters, 16, 786–789.
18.
SalveminiD., WangZ.Q., WyattP.S., BourdonD.M., MarinoM.H., ManningP.T., CurrieM.G. (1996) Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. British Journal of Pharmacology, 118, 829–838.
19.
RochaA.C., FernandesE.S., QuintãoN.L., CamposM.M., CalixtoJ.B. (2006) Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. British Journal of Pharmacology, 148, 688–695.
20.
BortalanzaL.B., FerreiraJ., HessS.C., Delle MonacheF., YunesR.A., CalixtoJ.B. (2002) Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. European Journal of Pharmacology, 453, 203–208.
21.
PosadasI., BucciM., RoviezzoF., RossiA., ParenteL., SautebinL., CirinoG. (2004) Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. British Journal of Pharmacology, 142, 331–338.
